8.65

0.35% -0.03

After Hours: 8.69 0.04 +0.46%

Kodiak Sciences Inc (KOD)

Overview News Price History Option Chain Financials Discussions Forecast

Kodiak Sciences Inc stock is traded at $8.65, with a volume of 317.81K. It is down -0.35% in the last 24 hours and up +49.40% over the past month. Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Previous Close:

$8.68

Open:

$8.44

24h Volume:

317.81K

Relative Volume:

0.90

Market Cap:

$455.20M

Revenue:

Net Income/Loss:

$-197.68M

P/E Ratio:

-1.5175

EPS:

-5.7

Net Cash Flow:

$-158.88M

1W Performance:

+2.13%

1M Performance:

+49.40%

6M Performance:

+243.25%

1Y Performance:

+210.04%

1-Day Range:

$8.33

$8.95

1-Week Range:

$8.03

$9.55

52-Week Range:

$2.185

$11.60

Kodiak Sciences Inc Stock (KOD) Company Profile

Name

Kodiak Sciences Inc

Sector

Healthcare (1176)

Industry

Biotechnology (673)

Phone

650-281-0850

Address

1200 PAGE MILL RD, PALO ALTO, CA

Employee

108

Twitter

@kodiaksciences

Next Earnings Date

2024-11-12

Latest SEC Filings

KOD's Discussions on Twitter

Compare KOD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KOD Kodiak Sciences Inc	8.65	455.20M	0	-197.68M	-158.88M	-3.76
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-24	Upgrade	Jefferies	Hold → Buy
Sep-05-24	Initiated	H.C. Wainwright	Neutral
Dec-11-23	Resumed	Goldman	Sell
Nov-17-23	Upgrade	CapitalOne	Equal Weight → Overweight
Jul-27-23	Downgrade	UBS	Buy → Neutral
Jul-25-23	Downgrade	Chardan Capital Markets	Buy → Neutral
Jul-25-23	Downgrade	JP Morgan	Neutral → Underweight
Jul-24-23	Downgrade	CapitalOne	Overweight → Equal Weight
Jul-24-23	Downgrade	Jefferies	Buy → Hold
Nov-15-22	Initiated	CapitalOne	Overweight
Aug-02-22	Downgrade	Citigroup	Neutral → Sell
Feb-24-22	Downgrade	JP Morgan	Overweight → Neutral
Feb-11-22	Initiated	Goldman	Buy
Feb-02-22	Upgrade	JP Morgan	Neutral → Overweight
May-11-21	Upgrade	ROTH Capital	Neutral → Buy
Mar-12-21	Initiated	Evercore ISI	Outperform
Mar-01-21	Downgrade	Barclays	Equal Weight → Underweight
Feb-17-21	Downgrade	ROTH Capital	Buy → Neutral
Jan-25-21	Downgrade	BMO Capital Markets	Outperform → Market Perform
Dec-17-20	Initiated	Berenberg	Buy
Dec-16-20	Initiated	UBS	Buy
Dec-11-20	Initiated	Citigroup	Neutral
Nov-30-20	Downgrade	JP Morgan	Overweight → Neutral
Nov-16-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-13-20	Downgrade	Goldman	Buy → Neutral
Mar-31-20	Initiated	BMO Capital Markets	Outperform
Mar-03-20	Initiated	Goldman	Buy
Feb-18-20	Downgrade	Barclays	Overweight → Equal Weight
Feb-06-20	Initiated	SunTrust	Buy
Jan-08-20	Initiated	ROTH Capital	Buy
Jan-03-20	Initiated	Jefferies	Buy
Dec-24-19	Initiated	JP Morgan	Overweight
Oct-15-19	Reiterated	Chardan Capital Markets	Buy
Feb-20-19	Initiated	Chardan Capital Markets	Buy
Oct-29-18	Initiated	Barclays	Overweight
Oct-29-18	Initiated	BofA/Merrill	Buy
Oct-29-18	Initiated	Morgan Stanley	Overweight

View All

Kodiak Sciences Inc Stock (KOD) Latest News

Dec 19, 2024

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Bought by Fmr LLC - Defense World

Dec 19, 2024

Dec 15, 2024

Kodiak Sciences' SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com South Africa

Dec 15, 2024

Kodiak Sciences' SWOT analysis: biotech stock faces pivotal year ahead - Investing.com India

Dec 15, 2024

Critical Survey: Allogene Therapeutics (NASDAQ:ALLO) versus Kodiak Sciences (NASDAQ:KOD) - Defense World

Dec 15, 2024

Dec 13, 2024

Nona Biosciences and Kodiak Sciences Partner on Next-Generation Antibody Therapies for Ophthalmic Diseases - The Eastern Progress Online

Dec 13, 2024

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate - Simply Wall St

Dec 13, 2024

Dec 10, 2024

KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential - MSN

Dec 10, 2024

Nona Biosciences Partners With Kodiak Sciences For Ophthalmic Antibody Discovery - Contract Pharma

Dec 10, 2024

Nona Biosciences and Kodiak Sciences Inc. Partners on Next-Generation Antibody Therapies for Ophthalmic Diseases - Marketscreener.com

Dec 10, 2024

Nona Biosciences, Kodiak Sciences partner on antibody therapies for ophthalmic diseases - Seeking Alpha

Dec 10, 2024

Dec 09, 2024

Kodiak Sciences Partners with Nona Biosciences for Novel Eye Disease Antibody Development - StockTitan

Dec 09, 2024

Jefferies Upgrades Kodiak Sciences (KOD) - MSN

Dec 09, 2024

Kodiak stock rallies 32% after Jefferies upgrades to buy - MSN

Dec 09, 2024

Pactiv Evergreen, RealReal, Kodiak Sciences And Other Big Stocks Moving Higher On Monday - Benzinga

Dec 09, 2024

Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock - Yahoo Finance

Dec 09, 2024

Kodiak Sciences shares initiated with buy rating on positive outlook By Investing.com - Investing.com South Africa

Dec 09, 2024

Kodiak stock rallies 32% after Jefferies upgrades to buy (NASDAQ:KOD) - Seeking Alpha

Dec 09, 2024

Kodiak Sciences shares initiated with buy rating on positive outlook - Investing.com

Dec 09, 2024

Kodiak Sciences (NASDAQ:KOD) Upgraded to "Buy" at Jefferies Financial Group - MarketBeat

Dec 09, 2024

Jacobs Levy Equity Management Inc. Sells 118,375 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - MarketBeat

Dec 09, 2024

Dec 07, 2024

Kodiak Sciences stock hits 52-week high at $7.81 By Investing.com - Investing.com Canada

Dec 07, 2024

Dec 06, 2024

Kodiak Sciences stock hits 52-week high at $7.81 - Investing.com India

Dec 06, 2024

Nov 25, 2024